NCT07684430

Brief Summary

This single-blind randomized controlled trial evaluated the effectiveness of a digital health education program delivered through WhatsApp in improving the quality of life of women with polycystic ovary syndrome (PCOS). Seventy women diagnosed with PCOS were enrolled from selected gynecology clinics in Imo State, Nigeria, and allocated to either an intervention group or a routine care control group. The intervention consisted of a four-week digital education program including 30 evidence-based educational messages. Quality of life was measured using the Polycystic Ovary Syndrome Quality of Life Questionnaire (PCOSQ) at baseline and one month after completion of the intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 25, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 24, 2026

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

June 29, 2026

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 6, 2026

Completed
Last Updated

July 6, 2026

Status Verified

June 1, 2026

Enrollment Period

2 months

First QC Date

June 29, 2026

Last Update Submit

June 29, 2026

Conditions

Keywords

Digital HealthHealth EducationSelf-ManagementQuality of LifeHealth Promotion

Outcome Measures

Primary Outcomes (1)

  • Change in Quality of Life

    The primary outcome measure evaluates changes in the quality of life of women diagnosed with polycystic ovary syndrome (PCOS) following the digital health education program. Quality of life is assessed using the Polycystic Ovary Syndrome Quality of Life Questionnaire (PCOSQ), a validated 26-item disease-specific instrument that measures emotional disturbances, body hair concerns, weight concerns, infertility problems, and menstrual problems. Higher scores indicate better quality of life.

    Baseline (before the intervention) and 1 month after completion of the intervention.

Study Arms (2)

Digital Health Education Program

EXPERIMENTAL

Participants in this group received a four-week digital health education program delivered through WhatsApp. The intervention provided structured educational messages designed to improve knowledge, self-management, and quality of life among women with polycystic ovary syndrome (PCOS).

Behavioral: Digital Health Education Program

Routine Care

ACTIVE COMPARATOR

Participants in this group received routine care and standard health information provided by the participating women's health wards and gynecology clinics. No digital health education program was provided during the study period.

Behavioral: routine care

Interventions

Participants received a four-week digital health education program delivered through WhatsApp. The intervention consisted of 30 structured educational messages covering polycystic ovary syndrome (PCOS), lifestyle modification, nutrition, physical activity, stress management, fertility, and prevention of long-term complications. Participants were encouraged to ask questions through WhatsApp, and researchers provided clarification when needed.

Digital Health Education Program
routine careBEHAVIORAL

Participants received routine care and standard health information provided by the participating women's health wards and gynecology clinics. They did not receive the digital health education program during the study period. After completion of data collection, the educational materials were provided to participants in the control group.

Routine Care

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen diagnosed with polycystic ovary syndrome (PCOS) who meet the study eligibility criteria are eligible to participate.
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women diagnosed with polycystic ovary syndrome
  • Women aged 18-45 years
  • Women attending the selected women's health wards and gynecology clinics during the study period
  • Willingness to participate and provide written informed consent

You may not qualify if:

  • Withdrawal of consent at any stage of the study
  • Failure to complete either the pre-test or post-test assessments
  • Incomplete participation in the educational intervention program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pouran Varvani Farahani

Nicosia, Haspolat, Cyprus

Location

MeSH Terms

Conditions

Polycystic Ovary SyndromeHealth Education

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System DiseasesAdherence InterventionsMedication AdherencePatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Pouran Varvani Farahani, PhD

    PhD in Pediatric Nursing, Department of Nursing, Faculty of Health Science, Cyprus International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
To reduce bias, the outcome assessor and the statistician responsible for data analysis were blinded to group assignments.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants were assigned to two parallel groups. Women in the intervention group received a four-week digital health education program delivered through WhatsApp, while women in the control group received routine care. Quality of life was assessed at baseline and one month after completion of the intervention using the Polycystic Ovary Syndrome Quality of Life Questionnaire (PCOSQ) to evaluate the effectiveness of the digital health education program.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD in Pediatric Nursing, Department of Nursing, Faculty of Health Science, Cyprus International University

Study Record Dates

First Submitted

June 29, 2026

First Posted

July 6, 2026

Study Start

April 25, 2026

Primary Completion

June 24, 2026

Study Completion

June 30, 2026

Last Updated

July 6, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

There is no plan to make IPD available to other researchers

Locations